The document summarizes key changes in the 8th edition of the American Joint Committee on Cancer (AJCC) head and neck cancer staging manual. It notes changes to the T categories for nasopharynx, oral cavity and skin cancers to incorporate depth of invasion. It also includes the addition of extra-nodal extension to the N category for lymph node metastases. The summary highlights limitations of the TNM system and discusses the future of incorporating additional prognostic factors into cancer staging to improve accuracy and predictive ability.
This powerpoint describes the types of maxillectomy & operative steps for total maxillectomy. It also enumerates various flaps used for reconstruction of maxillectomy defect.
ORN is an inflammatory condition of bone that occurs after the bone has been exposed to therapeutic doses of radiation usually given for a malignancies.
the role of brachytherapy in oral cavity carcinoma.
physics of brachytherapy
radiobiology of brachytherapy
clinical application in tongue, buccal mucosa cancer
New AJCC/UICC Staging System for Head & Neck, and Thyroid CancerHimanshu Soni
The AJCC/UICC staging system is a major tool in oncology, currently used worldwide for clinical,
pathological and recurrent disease staging. The objective of this presentation is to
describe the characteristics of the TNM staging system and review the changes made to head and neck
cancer staging in the most recent (8th) edition.
This powerpoint describes the types of maxillectomy & operative steps for total maxillectomy. It also enumerates various flaps used for reconstruction of maxillectomy defect.
ORN is an inflammatory condition of bone that occurs after the bone has been exposed to therapeutic doses of radiation usually given for a malignancies.
the role of brachytherapy in oral cavity carcinoma.
physics of brachytherapy
radiobiology of brachytherapy
clinical application in tongue, buccal mucosa cancer
New AJCC/UICC Staging System for Head & Neck, and Thyroid CancerHimanshu Soni
The AJCC/UICC staging system is a major tool in oncology, currently used worldwide for clinical,
pathological and recurrent disease staging. The objective of this presentation is to
describe the characteristics of the TNM staging system and review the changes made to head and neck
cancer staging in the most recent (8th) edition.
This seminar is presented as a part of weekly journal club and seminar regularly conducted at Apollo hospital,Kolkata Department of Radiation oncology.
The 2016 World Health Organization classification of tumors of the central nervous system broadly employs genetic alterations for diagnostic criteria including isocitrate dehydrogenase-1 (IDH1) mutation or IDH2 mutation, and 1p/19q codeletion,[1] with the goal of creating more homogeneous disease categories with greater prognostic value.[2-5] Molecular diagnostics is becoming an increasingly important aspect of clinical oncologic neuropathology practice.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
5. INTRODUCTION
Assigning the proper clinical and pathological stage is one of the
key activities for clinicians caring for those afflicted with cancer.
Staging is based on anatomic and non-anatomic criteria to assist
in estimating prognosis and planning treatment.
6. Background on the AJCC Head and Neck Task Force
hazard
consistency
hazard
discrimination
balance between
groups
high predictive
ability
7. OVERVIEW
1. Changes to the T categories in nasopharynx, oral cavity and
skin(DOI & PNI)
2. Alterations in N category in nasopharynx
3. Addition of extra-nodal extension (ENE) by tumor in a
metastatic lymph node (N category)
8. Changes to the T category
The T category acknowledges the different biological behavior
of deeply invasive but small tumors and incorporates depth of
invasion (DOI)
Recent data: DOI >>> tumor thickness
6th edition – DOI has been recorded and available for analysis.
DOI is distinct from tumor thickness.
9. Assessing DOI by clinical examination
Clinicians will need to distinguish a thick, exophytic, but less
invasive tumor from one that is ulcerated and deeply invasive
through careful palpation, supplemented by radiographic
assessment.
10. ….change
Staging will no longer depend solely upon the greatest surface
dimension.
For every 5mm increase in DOI, both cT and pT categories
will increase one level.
11. Pathologically, DOI is measured from the level of the basement
membrane of the closest adjacent normal mucosa. A ‘PLUMB
LINE’ is dropped from this plane to the deepest point of tumor
invasion.
12.
13. Key point
• Tumor thickness underestimates aggressive potential
• DOI is superior to tumor thickness
14.
15.
16. ENE in N categorization
ENE has been added as a prognostic variable for regional
lymph node metastases in addition to the number and size
of metastatic lymph nodes.
17. ….problem with stage migration
Current imaging modalities have significant limitations
and lack sensitivity and specificity in their ability to
identify early or minor ENE.
What is Stage migration…..??
18.
19.
20.
21. ….cENE positive status?
Clinical staging of ENE is determined by physical examination:
e.g.
1. invasion of skin,
2. infiltration of musculature/dense tethering to adjacent
structures, or
3. Dysfunction of cranial nerve, the brachial plexus, the
sympathetic trunk, or phrenic nerve
and supported by radiological evidence, should be present to
assign a status of ENE-positive
22. ….pENE positive status?
Pathological ENE is defined as extension of metastatic carcinoma
from within a lymph node through the fibrous capsule and into
the surrounding connective tissue, regardless of the presence of
stromal reaction.
Pathological ENE can be minor or major extension.
Metastatic carcinoma that stretches the capsule but does not breach
it does not constitute ENE
Minor ENE (ENEmi)
defined as extension of
≤2mm from the capsule
Major ENE (ENEma)
defined as either extension apparent to
pathologist naked eye or
>2mm beyond the capsule microscopically.
23. Conclusion……..
The 8th edition head and neck AJCC cancer staging manual
incorporates significant changes which include:
1. A separate staging algorithm for HPV-assosiated cancer of the
oropharynx.
2. Changes to the tumor T categories in the nasopharynx, oral
cavity, and skin.
3. And addition of tumor ENE to the lymph node category for
most sites.
24. How good is this update?
1. Inherent drawbacks of the TNM staging
2. Future of cancer staging
3. When applied to Indian scenario ….!!
25. Drawbacks of TNM system
Is it workable ?????– YES
1. But the TNM system takes into consideration only
the anatomic factors of the tumor, and not patient
related factors such as smoking, alcohol, pulmonary
status, general medical condition (life style and
comorbidities)
2. It is a static system and stages patients only at the
time of initial diagnosis
3. The TNM system does not include ‘response to
therapy’ and thus is not dynamic.
26. Future directions
Incorporation of TNM and other tumor parameters such as
histo-morphological features,
molecular markers,
Non-anatomic prognostic factors,
life style and comorbidities
response to therapy.
Dynamic Personalized Prognostic Nomograms
27.
28.
29.
30.
31.
32. Staging
It is a continuously evolving and dynamic process
incorporating new and valid information to improve
accuracy and predictive power.
Frequency of revision: previous update -2010
Too frequent revisions: Not be able to generate
comparative data, to show outcomes of the disease and
therapy
On the other hand new discoveries and new knowledge
must be incorporated to continually improve
Compromise between ‘ideal’ and ‘practical’
33. References
Lydiatt, W., Patel, S., O'Sullivan, B., Brandwein, M., Ridge, J.,
Migliacci, J., Loomis, A. and Shah, J. (2017). Head and neck
cancers-major changes in the American Joint Committee on
cancer eighth edition cancer staging manual. CA: A Cancer
Journal for Clinicians, 67(2), pp.122-137.
Groome P, Schulze K, Boysen M, Hall S, Mackillop W. A
comparison of published head and neck stage groupings in
carcinomas of the oral cavity. Head & Neck. 2001;23(8):613-624.
Pai P, Tuljapurkar V, Dhar H, Mishra A, Chakraborti S,
Chaturvedi P. The Indian scenario of head and neck oncology -
Challenging the dogmas. South Asian Journal of Cancer.
2016;5(3):105.
Groome et al described:
Stratification should result in similar survival for each subgroup – hazard consistency
Each subgroup should have different survival from the one above and below – hazard discrimination
There is should be relatively equal number of subjects in each group to facilitate statistical analysis – balance between groups
The assigned stage should give a good approximation of survival for the individual patient – high predictive ability
Primary tumor (T) categories (for size/extent of the primary tumor) have been revised in OCC, NMSC, and nasopharyngeal cancer
It has been recognized for decades that the prognosis of OCC worsens when the tumor is thicker.
More recent data suggest that the DOI is a better predictive parameter than tumor thickness
Assessing DOI by clinical examination requires palpation and attention to detail.
Since the inception of TNM system, clinicians have been using physical examination to reflect subtle differences in size and extension of tumors, so distinguishing less invasive lesions (<5mm), from those of moderate depth (from >5mm to <10mm) or deeply invasive cancers (>10mm) should not be problematic.
The T category increases with every interval of 5mm.
Upstaged to T2 based on DOI of 9mm
Small exophytic cancer, DOI <<TT
Small ulcerated carcinima which has upstaged to T2 based on DOI of 6mm
The T category increases with every interval of 5mm.
Upstaged to T2 based on DOI of 9mm
Small exophytic cancer, DOI <<TT
Small ulcerated carcinima which has upstaged to T2 based on DOI of 6mm
The status of the regional lymph nodes in head and neck cancer has tremendous prognostic significance, so the cervical lymph nodes much be assessed for each patient.